Literature DB >> 11343037

The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children.

D Connolly1, M Rutkowski, M Auslender, M Artman.   

Abstract

OBJECTIVE: The assessment of the severity of heart failure in pediatric patients is handicapped by the subjectivity of diagnostic parameters. This study evaluated the feasibility of a new standardized heart failure index, the New York University Pediatric Heart Failure Index (NYU PHFI), to quantify the degree of heart failure in a selected pediatric population. METHODS AND
RESULTS: The index is a weighted, linear combination of scores based on symptoms, physical signs, and medical regimen. Overall, healthy children (n = 12) scored very low (0 to 2) on this index. Mean scores of children (<2 years; mean age, 4.8 months; n = 12) with a left-to-right shunt lesion declined from 11.4 (SD +/- 4.1, P <.001, 2-tailed test) before surgery to 1.8 (SD +/- 1.3) after surgical correction of their cardiac defects. The average inter-observer correlation coefficient was 0.95 (P <.001), despite a wide range of scores.
CONCLUSIONS: The NYU PHFI appears to be a reliable and convenient instrument for measuring heart failure severity in children. These initial results support further testing in broader diagnostic and age groups and over longer periods.

Entities:  

Mesh:

Year:  2001        PMID: 11343037     DOI: 10.1067/mpd.2001.114020

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

1.  The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children.

Authors:  J Soongswang; C Sangtawesin; K Durongpisitkul; D Laohaprasitiporn; A Nana; K Punlee; C Kangkagate
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

2.  Epidemiology of Pediatric Heart Failure in the USA-a 15-Year Multi-Institutional Study.

Authors:  Marc Anders; Susan Denfield; Raysa Morales-Demori; Elena Montañes; Gwen Erkonen; Michael Chance
Journal:  Pediatr Cardiol       Date:  2021-04-19       Impact factor: 1.655

Review 3.  Approach to a Child with Congestive Heart Failure.

Authors:  Manojkumar Rohit; Sudhansu Budakoty
Journal:  Indian J Pediatr       Date:  2020-04       Impact factor: 1.967

Review 4.  The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision.

Authors:  Robert D Ross
Journal:  Pediatr Cardiol       Date:  2012-04-05       Impact factor: 1.655

5.  NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.

Authors:  N Nasser; Z Perles; A J J T Rein; A Nir
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

Review 6.  Neurocognitive consequences of surgically corrected congenital heart defects: A review.

Authors:  M Miatton; D De Wolf; K François; E Thiery; G Vingerhoets
Journal:  Neuropsychol Rev       Date:  2006-09-08       Impact factor: 7.444

Review 7.  Heart failure in children in tropical regions.

Authors:  Manojkumar Rohit; Ankur Gupta; K K Talwar
Journal:  Curr Heart Fail Rep       Date:  2013-12

8.  Value of brain natriuretic peptide in the perioperative follow-up of children with valvular disease.

Authors:  Pierre Tissières; Eduardo da Cruz; Walid Habre; Yacine Aggoun; Noury Mensi; Afksendyios Kalangos; Maurice Beghetti
Journal:  Intensive Care Med       Date:  2008-02-19       Impact factor: 17.440

9.  Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress.

Authors:  S Koulouri; R J Acherman; P C Wong; L S Chan; A B Lewis
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

10.  Aminoterminal brain natriuretic peptide levels in children and adolescents after Fontan operation correlate with congestive heart failure.

Authors:  Evelyn Lechner; Roland Gitter; Rudolf Mair; Miklos Pinter; Elisabeth Schreier-Lechner; David Vondrys; Gerald Tulzer
Journal:  Pediatr Cardiol       Date:  2008-04-08       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.